Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Clinical trial NCT00003962 · COMPLETED

Trial details

NCT number: NCT00003962
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm

Start date: 1998-04-01
Primary completion: 2000-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.